NeuroSense Therapeutics NRSN Income Statement (2020-2025)

NASDAQ NRSN
$6.62 +0.27 (+4.25%)
At close: Sep 21, 2026 · 4:00 PM EDT
Reported Financials

NeuroSense Therapeutics Quarterly Income Statement

Periods 16 quarters
Latest Dec 2025

NeuroSense Therapeutics income statement data for the quarter ended Dec 2025. This income statement covers 16 quarters of results from Dec 2020 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

Income Statement Dec2020 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Jun2025 Dec2025
Operating items
Research & DevelopmentR&D 4.43M-1.30M4.46M-8.04M-0.71M-1.85M-1.96M-1.56M-1.91M-1.88M5.62M-8.35M-1.09M
Selling, General & AdministrativeSG&A -0.69M-1.97M-1.72M-1.61M0.33M-1.14M-1.41M-1.07M-1.16M-1.11M-1.18M-1.23M-0.69M
Operating ExpensesOpex 3.75M-3.26M2.74M-9.65M-0.38M-2.99M-3.37M-2.63M-3.06M-2.99M4.44M-9.57M-1.77M
Operating IncomeOp. Inc 0.96M-3.26M-3.59M-3.32M-0.38M-2.99M-3.37M-2.63M-3.06M-2.99M-3.03M-2.11M-1.77M
EBIT 0.96M-3.26M-3.59M-3.32M-0.38M-2.99M-3.37M-2.63M-3.06M-2.99M-3.03M-2.11M-1.77M
Non-operating items
Non Operating Interest Expenses -1.19M-0.02M-0.04M-0.01M0.10M-0.31M-1.89M-0.01M2.66M
Interest & Investment IncomeInt & Inv Inc 2.73M0.57M0.14M0.34M-1.11M0.06M-0.27M4.10M-5.83M
Non Operating IncomeNon Op. Inc. 0.55M-0.48M0.07M0.42M1.58M-0.12M-2.41M2.17M-0.04M-0.03M
Net income details
EBT 4.87M-2.67M-3.41M-2.97M-1.59M-2.62M-1.75M1.49M-11.55M-2.99M-3.03M-2.11M-1.77M
Profit After TaxPAT 7.16M-2.71M8.91M-15.39M-1.30M-2.92M-3.65M-0.35M-3.19M-5.40M11.66M-14.67M-1.80M
Income from Continuing OperationsIncome (Continuing) 4.87M-2.67M-3.41M-2.97M-1.59M-2.62M-1.75M1.49M-11.55M-2.99M-3.03M-2.11M-1.77M
Consolidated Net IncomeConsol Net Inc. 4.87M-2.67M-3.41M-2.97M-1.59M-2.62M-1.75M1.49M-11.55M-2.99M-3.03M-2.11M-1.77M
Income towards Parent CompanyParent Net Inc 4.87M-2.67M-3.41M-2.97M-1.59M-2.62M-1.75M1.49M-11.55M-2.99M-3.03M-2.11M-1.77M
Net Income towards Common StockholdersNet Income 4.87M-2.67M-3.41M-2.97M-1.59M-2.62M-1.75M1.49M-11.55M-2.99M-3.03M-2.11M-1.77M
Additional items
EPS (Basic) 0.78-0.43-0.55-0.48-0.14-0.23-0.150.13-0.85-0.22-0.22-0.15-0.10
EPS (Diluted) 0.78-0.43-0.55-0.48-0.14-0.23-0.150.13-0.85-0.22-0.22-0.15-0.10
Shares Outstanding 5.52M6.24M6.24M6.24M6.24M11.50M11.50M11.50M11.50M13.64M13.64M13.64M13.64M18.60M18.60M25.48M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 5.52M6.24M6.24M6.24M6.24M11.50M11.50M11.50M11.50M13.64M13.64M13.64M13.64M18.60M18.60M25.48M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 5.58M6.24M11.78M15.38M18.60M25.48M
EBITDA 0.96M-3.26M-3.59M-3.32M-0.38M-2.99M-3.37M-2.63M-3.06M-2.99M-3.03M-2.11M-1.77M
Interest ExpensesInt Expense -1.19M-0.02M-0.04M-0.01M0.10M-0.31M-1.89M-0.01M2.66M

NeuroSense Therapeutics Income Statement API

Pull NeuroSense Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=NRSN&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY